Beyond market trends, investors looking for superior returns explore the world of stock picking. The right selections can be a powerful driver for wealth accumulation.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Soleno Therapeutics Inc (NASDAQ: SLNO) closed the day trading at $55.31 up 0.71% from the previous closing price of $54.92. In other words, the price has increased by $0.71 from its previous closing price. On the day, 0.72 million shares were traded. SLNO stock price reached its highest trading level at $57.28 during the session, while it also had its lowest trading level at $54.96.
Ratios:
For a better understanding of SLNO, let’s look at its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 29.24 and its Current Ratio is at 29.24. In the meantime, Its Debt-to-Equity ratio is 0.00 whereas as Long-Term Debt/Eq ratio is at 0.00.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, H.C. Wainwright on September 03, 2024, initiated with a Buy rating and assigned the stock a target price of $70.
On May 10, 2024, Robert W. Baird started tracking the stock assigning a Outperform rating and target price of $72.
On February 05, 2024, Piper Sandler started tracking the stock assigning a Overweight rating and target price of $93.Piper Sandler initiated its Overweight rating on February 05, 2024, with a $93 target price.
Insider Transactions:
The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Oct 21 ’24 when Abingworth Bioventures VII LP bought 949,336 shares for $54.16 per share.
Abingworth Bioventures VII LP bought 2,522,751 shares of SLNO for $125,204,132 on Oct 07 ’24. On Oct 01 ’24, another insider, Yen Kristen, who serves as the insider of the company, sold 3,108 shares for $49.43 each. As a result, the insider received 153,627 and left with 81,465 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, SLNO now has a Market Capitalization of 2149988352 and an Enterprise Value of 1884160896.
Stock Price History:
Over the past 52 weeks, SLNO has reached a high of $56.81, while it has fallen to a 52-week low of $21.30. The 50-Day Moving Average of the stock is 9.14%, while the 200-Day Moving Average is calculated to be 19.89%.
Shares Statistics:
Over the past 3-months, SLNO traded about 602.17K shares per day on average, while over the past 10 days, SLNO traded about 587230 shares per day. A total of 31.68M shares are outstanding, with a floating share count of 27.68M. Insiders hold about 28.78% of the company’s shares, while institutions hold 78.69% stake in the company. Shares short for SLNO as of 1728950400 were 5710987 with a Short Ratio of 9.48, compared to 1726185600 on 4664397. Therefore, it implies a Short% of Shares Outstanding of 5710987 and a Short% of Float of 23.82.
